45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
20,566
Insurances with rates
39
CPT / HCPCS codes
12,442
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 510020263 | vutrisiran 25 mg/0.5 mL syringe | $424,154 | $190,869 | — | — | 22 |
| 510020266 | lumasiran 94.5 mg/0.5 mL inj | $407,533 | $183,390 | — | — | 22 |
| 510020195 | tebentafusp-tebn 100 mcg/0.5 mL inj | $193,897 | $87,254 | — | — | 22 |
| 510018653 | tagraxofusp-erzs (Elzonris) 1000 mcg inj | $160,682 | $72,307 | — | — | 22 |
| 510013649 | ustekinumab 45 mg/0.5 mL inj | $135,292 | $60,881 | — | — | 22 |
| 510013713 | ustekinumab 90 mg/1 mL inj | $135,292 | $60,881 | — | — | 22 |
| 510020157 | loncastuximab tesirine-lpyl 10 mg inj | $132,168 | $59,476 | — | — | 22 |
| 510020127 | lanreotide 90 mg syringe | $127,939 | $57,573 | — | — | 22 |
| 510017501 | ribavirin 6,000 mg Inhalation powder | $118,816 | $53,467 | — | — | 22 |
| 510016295 | alemtuzumab (Lemtrada) 12 mg/1.2 mL inj | $115,661 | $52,047 | — | — | 22 |
| 510018575 | inotuzumab ozogamicin 0.9 mg inj | $108,442 | $48,799 | — | — | 22 |
| 510017419 | porfimer 75 mg Inj | $97,233 | $43,755 | — | — | 22 |
| 510018667 | polatuzumab vedotin-piiq 140 mg inj | $88,103 | $39,646 | — | — | 22 |
| 510018741 | fluocinolone acetonide intravitreal 0.59 mg implant | $86,870 | $39,092 | — | — | 22 |
| 510018748 | teprotumumab-trbw (Tepezza) 500 mg inj | $85,307 | $38,388 | — | — | 22 |
| 510016458 | vinCRIStine liposome 5 mg/31 mL kit | $74,553 | $33,549 | — | — | 22 |
| 510017356 | pegloticase 8 mg/1 mL inj | $66,640 | $29,988 | — | — | 22 |
| 482561518 | ULH PET F-18 AMYVID | $63,000 | $28,350 | — | — | 22 |
| 483061518 | ULH PET F-18 AMYVID | $63,000 | $28,350 | — | — | 22 |
| 510020107 | leuprolide (Lupron) *6 Month* 45 mg *IntraMuscular* | $57,793 | $26,007 | — | — | 22 |
| 510016642 | brentuximab vedotin 50 mg inj | $57,758 | $25,991 | — | — | 22 |
| 510018834 | luspatercept-aamt 75 mg inj | $57,267 | $25,770 | — | — | 22 |
| 510018281 | lanreotide 120 mg syringe (J1932/nonpreferred) | $47,790 | $21,505 | — | — | 22 |
| 510011289 | gemtuzumab ozogamicin 4.5 mg inj | $47,551 | $21,398 | — | — | 22 |
| 510016253 | vedolizumab 300 mg inj | $44,308 | $19,939 | — | — | 22 |
| 510018647 | caplacizumab-YHDP (Cablivi) 11 mg inj | $40,577 | $18,260 | — | — | 22 |
| 510016572 | antivenin (Micrurus fulvius) inj 10 mL | $40,003 | $18,001 | — | — | 22 |
| 510010082 | alteplase 100 mg/100 mL inj | $39,494 | $17,772 | — | — | 22 |
| 510011677 | leuprolide (Lupron) *4 Month* 30 mg *IntraMuscular* | $38,528 | $17,338 | — | — | 22 |
| 510020033 | lurbinectedin 4 mg inj | $38,391 | $17,276 | — | — | 22 |
| 510013564 | tenecteplase 50 mg inj (myocardial infarction) | $37,145 | $16,715 | — | — | 22 |
| 510012316 | pegfilgrastim (Neulasta) 6 mg/0.6 mL inj | $35,852 | $16,133 | — | — | 22 |
| 510016297 | pegfilgrastim (Neulasta) DELIVERY KIT 6 mg/0.6 mL | $35,852 | $16,133 | — | — | 22 |
| 470078958 | NGS OF DNA & RNA IN TUMOR TISSUE | $35,775 | $16,099 | — | — | 22 |
| 510020150 | tisotumab vedotin-tftv 40 mg vial | $33,722 | $15,175 | — | — | 22 |
| 510018208 | talimogene lah 100 million [PFU]/mL | $33,249 | $14,962 | — | — | 22 |
| 510020261 | teclistamab-cqyv 153 mg/1.7 mL inj | $32,472 | $14,613 | — | — | 22 |
| 510010067 | alemtuzumab (Campath) 30 mg/1 mL inj | $31,556 | $14,200 | — | — | 22 |
| 510020209 | pegfilgrastim-BMEZ (Ziextenzo) 6 mg/0.6 mL inj | $31,143 | $14,014 | — | — | 22 |
| 510012195 | octreotide LAR 30 mg kit | $30,711 | $13,820 | — | — | 22 |
| 510015688 | ado-trastuzumab emtans 160 mg inj | $30,218 | $13,598 | — | — | 22 |
| 510020109 | siltuximab 400 mg inj | $30,135 | $13,561 | — | — | 22 |
| 510011674 | leuprolide (Lupron) *3 Month* 22.5 mg *IntraMuscular* | $28,896 | $13,003 | — | — | 22 |
| 510014446 | ixabepilone 45 mg inj | $28,610 | $12,874 | — | — | 22 |
| 510010878 | digoxin immune fab 40 mg inj | $26,543 | $11,944 | — | — | 22 |
| 510018213 | blinatumomab 35 mcg pwd Inj | $26,302 | $11,836 | — | — | 22 |
| 510018635 | romiPLOStim 500 mcg/1 mL inj | $26,062 | $11,728 | — | — | 22 |
| 510014876 | rasburicase 7.5 mg inj | $25,814 | $11,616 | — | — | 22 |
| 510018620 | pegfilgrastim-CBQV (Udenyca) 6 mg/0.6 mL inj | $25,693 | $11,562 | — | — | 22 |
| 510010433 | carmustine 7.7 mg wafer | $25,133 | $11,310 | — | — | 22 |
Showing top 50 of 20,566 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.